Status | Study |
Not yet recruiting |
Study Name: Safety and Efficacy of Various Doses and Treatment Durations of Linezolid Plus Bedaquiline and Pretomanid in Participants With Pulmonary TB, XDR-TB, Pre- XDR-TB or Non-responsive/Intolerant MDR-TB (ZeNiX) Condition: Tuberculosis, Pulmonary Tuberculosis, Multidrug-Resistant Date: 2017-03-07 Interventions: Drug: Pretomanid 200mg tablets |
Recruiting |
Study Name: Pragmatic Clinical Trial for a More Effective Concise and Less Toxic MDR-TB Treatment Regimen(s) Condition: Tuberculosis, Multidrug-Resistant Extensively Drug-Resistant Tuberculo Date: 2015-10-15 Interventions: Drug: Bedaquiline Other Names: |
Recruiting |
Study Name: An Open-label RCT to Evaluate a New Treatment Regimen for Patients With Multi-drug Resistant Tuberculosis Condition: Tuberculosis Multidrug Resistant Tuberculosis Date: 2015-05-22 Interventions: Drug: Linezolid 600mg Linezoli |
Completed |
Study Name: Ultralow Dose Computed Tomography in High-risk Drug-resistant Tuberculosis Contacts Condition: Latent Tuberculosis Date: 2015-05-22 Interventions: Radiation: Ultralow dose chest CT scan Ultralow-dose chest CT scan is performed using a 64-row multidete |
Recruiting |
Study Name: A Phase 3 Study Assessing the Safety and Efficacy of Bedaquiline Plus PA-824 Plus Linezolid in Subjects With Drug Resistant Pulmonary Tuberculosis Condition: Pulmonary Tuberculosis Date: 2015-01-06 Interventions: Drug: Bedaquiline 100mg tablet |
Completed |
Study Name: Global Consortium for Drug-resistant Tuberculosis Diagnostics Condition: Tuberculosis Tuberculosis, Multidrug-Resistant Date: 2014-06-12 |
Withdrawn |
Study Name: A Study to Evaluate the Efficacy and Safety of TMC207 in Patients With Pulmonary Infection With Multi-drug Resistant Mycobacterium Tuberculosis Condition: Multi-drug Resistant Tuberculosis Date: 2012-04-24 Interventions: Drug: Arm A Double-blind Phase: TMC207 |
Completed |
Study Name: Drug Interaction Study Between Linezolid and Clarithromycin in Tuberculosis Patients Condition: Multidrug-resistant Tuberculosis Extensively Drug-resistant Tuberculos Date: 2011-09-13 Interventions: Drug: Addition of different doses of clarithromycin. At we |
Terminated |
Study Name: Utility of MODS for Diagnosis of MDR-TB and Second-Line Antituberculous Drug Susceptibility Testing in Mali Condition: Tuberculosis, Pulmonary Mycobacterium Tuberculous Antitube Date: 2011-06-23 |
Completed |
Study Name: Safety and Efficacy of Oral Immunomodulator in Tuberculosis (TB) and TB/HIV Patients Condition: Tuberculosis Date: 2010-06-30 Interventions: Biological: V-5 immunitor once per day dosing for 2 months |